Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
NCT Number: NCT02088788
Radiation exposure to operator is an occupational hazard of invasive cardiologists. During radial access for diagnostic catheterization, a new radio-dense arm board is advertised to reduce operator radiation exposure. The investigators randomize patients to a new radio-dense armboard versus a standard radio-transparent armboard during diagnostic catheterization and measure radiation exposure to the operator. Both groups have a radio-dense pelvic shield in place. The investigators hypothesize that operator radiation dose will be decreased by use of the radio-dense armboard.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Interventional
Not applicable
Danville, Pennsylvania, 17822, United States
Hypothesis:
Compared to standard shielding with a lead pelvic drape alone, using a radio-opaque arm board in addition to the pelvic drape will decrease operator radiation exposure during radial access cardiac catheterization by at least 30%.
STUDY DESIGN This is a randomized, prospective study where patients will be randomized by random numbers in sealed envelopes to standard shielding (pelvic drape alone, the "no-board group") or to experimental shielding (pelvic drape plus radiation board, the "board group").
A robust radiation safety monitoring program is in place. Patient exposure is measured by the catheterization laboratory equipment and recorded. Lindauer Microstar Nanodot badges worn at waist level above the radiation lead will be used to measure operator radiation exposure. A new Nanodot will be used for every case. Radiation exposure to the operator's Nanodot will be measured immediately after each procedure by a technician blinded to study assignment.
All patients 18-89 years old presenting to Geisinger Medical Center for diagnostic cardiac catheterization will be evaluated for the study. All interventional or diagnostic cardiologists and fellows that will be performing the cardiac catheterization procedure also will be study subjects. Approximately 215 Geisinger patients who satisfy inclusion and exclusion criteria will be included. Approximately 6 interventional cardiologists, 2 diagnostic cardiologists and 10 fellows will be included in this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Operators: Interventional or diagnostic interventional attendings and fellows, operators willing to participate.
Patients: Age 18-89 years old requiring catheterization at Geisinger Medical Center using radial access
Exclusion criteria
Also has radio-dense pelvic shielding
Other names: "Rad Board"
Radio-lucent armboard for radial access with radio-dense drape across pelvis
Time frame: during initial diagnostic catheterization procedure, an average of 30 minutes
mSieverts radiation dose to the operator during diagnostic catheterization
Time frame: During procedure, an average of 35 minutes
mSieverts radiation dose to the operator during diagnostic catheterization with versus without ventriculography/aortography. This outcome measure includes 2 types of procedures: diagnostic catheterization plus LV gram and diagnostic catheterization plus aortography. Ventriculography is defined as injection through a pigtail catheter into the left ventricle using a power injector. Aortography is defined as injection through a pigtail catheter into the aorta using a power injector.
Geisinger Clinic
Other
Reduction in Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a Radiation Protection Board
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06875583
Radiation Exposure, Radiation Exposure to Operator
Liverpool, United Kingdom
View Trial DetailsNCT07528144
Endovascular Aortic Repair, Musculoskeletal Strain
Szczecin, West Pomeranian Voivodeship, Poland
View Trial DetailsNCT04670016
Brain Diseases, Brain Neoplasms
Calgary, Alberta, Canada
View Trial DetailsNCT02259218
Adult Brain Tumor, Brain Diseases
Columbus, Ohio, United States
View Trial Details